A class of drugs that inhibit the proto-oncogene c-Kit, also called mast/stem cell growth factor receptor. Actionable mutations of KIT are seen in gastrointestinal stromal tumors, mast cell disease, seminoma, melanoma, and acute myeloid leukemia